GoodRx Holdings (GDRX) Short-term Investments (2020 - 2021)
GoodRx Holdings recorded quarterly Short-term Investments of $2.9 million in Q1 2021, little changed quarter-over-quarter from $2.9 million in Q4 2020.
GoodRx Holdings' Short-term Investments history runs 2 years deep, the most recent figure standing at $2.9 million for Q1 2021.
- In Q1 2021, Short-term Investments changed N/A year-over-year to $2.9 million; the TTM figure through Mar 2021 stood at $2.9 million (changed N/A YoY), while the FY2020 annual figure was $2.9 million, changed N/A from the prior year.
- Short-term Investments came in at $2.9 million for Q1 2021 at GoodRx Holdings, roughly flat from $2.9 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $2.9 million in Q3 2020 to a low of $2.9 million in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | GoodRx Holdings | 1.05 Bn | 814.83 Mn | 112.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 2.90 Mn |
| Dec 31, 2020 | 2.90 Mn |
| Sep 30, 2020 | 2.90 Mn |